COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • March 23rd, 2023 • CymaBay Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 23rd, 2023 Company Industry JurisdictionThis COLLABORATION AND LICENSE AGREEMENT (this “Agreement”), dated as of January 6, 2023 (the “Effective Date”), is entered into by and between CymaBay Therapeutics, Inc., a Delaware corporation (“CymaBay”), and Kaken Pharmaceutical Co., Ltd., a company organized under the laws of Japan (“Kaken”). CymaBay and Kaken may be referred to in this Agreement individually as a “Party” and collectively as the “Parties”.